CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
about
Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogelsPC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesisNon-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesEpigenetic regulation of CpG promoter methylation in invasive prostate cancer cellsRole of moesin in hyaluronan induced cell migration in glioblastoma multiformePharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerActivation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylationThe androgen receptor and stem cell pathways in prostate and bladder cancers (review)Targeting prostate cancer stem cells for cancer therapyProstate cancer and parasitism of the bone hematopoietic stem cell nicheProstate Cancer Stem Cells: Research AdvancesThe role of prostate tumor overexpressed 1 in cancer progressionCancer stem cells in basic science and in translational oncology: can we translate into clinical application?The cancer stem cell niche--there goes the neighborhood?Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancerA small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of conceptCD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular CarcinomaMicroenvironmental modulation of asymmetric cell division in human lung cancer cells.The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.Genomic profiling of tumor initiating prostatospheres.A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children.Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cellsGossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.More than markers: biological significance of cancer stem cell-defining molecules.Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters.Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.The human airway epithelial basal cell transcriptome.Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population.Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent stateScreening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.Activation of c-MET induces a stem-like phenotype in human prostate cancerProstate cancer cell lines under hypoxia exhibit greater stem-like properties.Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cellsCell-to-cell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors.Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) traffickingA 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells
P2860
Q21090839-6B560A2B-C3C1-4A9F-B434-D0DD397FDCF6Q21245704-A39F36A1-FA20-4203-AE59-A40AB9D10B3FQ21562142-8CDC16C2-B623-486E-9BEB-A8E1AEC84747Q24302022-2ADACB7B-0201-4A0F-85F3-D15EAA7D88CEQ24307954-37911D46-1364-43FF-9170-B75B7BEDF27CQ24632276-0EFEC572-0EC6-4DD3-BFEE-CFAC2DA798ECQ24632832-A8420C7F-923C-4CD2-8EF4-C2E36CF20526Q26853232-31F53AAE-A5AB-4B3C-A83F-7C00198D1FC2Q26865693-87558805-1416-4548-9857-90A62CF86C21Q26996231-094613E2-5CF7-4AF6-89D0-7AF30ECE0C14Q26998435-04A602B7-A93E-480A-BC11-68B277438AE8Q28079350-DEB392C9-FE00-4FDC-9F31-5ECC5150AFE2Q28081844-F800A568-17BA-416A-AFDF-EB0578EABF1AQ28244178-EC471B43-CE25-489D-A752-6938A2C8CF57Q28392741-EE42114C-03C9-463B-82A6-3FE8918D4933Q28486414-64B49015-F0F8-41AB-8306-8F5739E8850DQ28550134-6B2AA797-3069-4848-9D35-AD46630EAC55Q30493589-53271616-A437-4F12-AAC4-86626BB9453EQ31137385-CA31214B-6F93-4948-9FA1-5B46A2E76FA5Q33562480-4BF83339-DFA4-40D1-A9D5-ED511D88DC90Q33586722-BBBFFDE1-5C0E-4A11-9FFA-C2CBD0407398Q33616598-CAEA60AE-91AA-45A7-8D0B-2F7FDF02978DQ33637076-D71FEC34-2680-4DF1-8CC9-3F100FA25ADFQ33647720-4CE7497F-3413-4ABA-9A29-BA35CA785406Q33661278-36B90FC5-4C47-478D-AE63-9250560CEF01Q33809987-C99BE9DD-F406-4155-B161-858B9BC4D60DQ33869770-6AEA0064-5CB3-46A4-BBD8-83E08DFCF8E2Q33900107-71211F50-8539-412D-A3B4-53B7B0895582Q33908497-6E9B14A4-47FD-452B-8856-CE2A98118EFDQ33914216-308230EE-5DBC-48AB-8A3D-FB56FB613919Q33919758-68C7287E-EB55-4154-AF99-5F6F0A45EA06Q34042492-B762E3E4-7DEA-4E89-9BCD-702E221DEB0CQ34081431-ECA3CCD8-1345-4C17-9773-D83D709BE23BQ34117287-84579C6F-634B-415B-922F-E76233598D08Q34126555-88E5E3D7-5EB9-4E4A-8120-339C11F3EC9AQ34157307-096ABDBC-99EA-4AEC-AB76-FBF2EDB51651Q34297111-96AC0A88-701E-4EE2-A835-E99573F7C04EQ34395138-D9E01BFC-3F8D-4310-837B-AE5EBA52296FQ34473316-E56CB94F-2BCC-4361-B100-F20C7D80B4B1Q34486457-A51D46C9-8B41-44BC-9618-021B2284D186
P2860
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@ast
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@en
type
label
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@ast
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@en
prefLabel
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@ast
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@en
P2093
P2860
P356
P1476
CD44+ CD24(-) prostate cells a ...... r patients with poor prognosis
@en
P2093
B T Kawasaki
G J Klarmann
S B Thomas
W L Farrar
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604242
P407
P577
2008-02-12T00:00:00Z